2023 Q4 Form 10-Q Financial Statement

#000163528223000202 Filed on November 01, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $112.1M $107.5M
YoY Change 3.21% 5.42%
Cost Of Revenue $43.71M $40.11M
YoY Change 13.35% 2.14%
Gross Profit $68.40M $67.34M
YoY Change -2.37% 7.47%
Gross Profit Margin 61.01% 62.67%
Selling, General & Admin $52.55M $53.98M
YoY Change -8.25% -0.76%
% of Gross Profit 76.83% 80.15%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $826.0K $750.0K
YoY Change 30.49% 15.56%
% of Gross Profit 1.21% 1.11%
Operating Expenses $52.55M $56.10M
YoY Change -8.25% -7.46%
Operating Profit $15.85M $11.24M
YoY Change 24.0% 452.29%
Interest Expense $787.0K $1.413M
YoY Change -153.0% 4181.82%
% of Operating Profit 4.97% 12.57%
Other Income/Expense, Net -$980.0K $990.0K
YoY Change -134.13% -174.49%
Pretax Income $11.35M $10.82M
YoY Change -371.02% -2446.2%
Income Tax $2.002M $4.015M
% Of Pretax Income 17.63% 37.12%
Net Earnings $9.351M $6.801M
YoY Change -277.37% -1779.26%
Net Earnings / Revenue 8.34% 6.33%
Basic Earnings Per Share $0.08
Diluted Earnings Per Share $0.10 $0.08
COMMON SHARES
Basic Shares Outstanding 89.39M shares 89.09M shares
Diluted Shares Outstanding 89.36M shares

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $125.3M $128.1M
YoY Change -3.0% -1.25%
Cash & Equivalents $115.4M $108.2M
Short-Term Investments $9.826M $19.90M
Other Short-Term Assets $44.01M $42.80M
YoY Change 20.61% 12.51%
Inventory
Prepaid Expenses $25.65M $24.68M
Receivables $119.4M $61.19M
Other Receivables $0.00 $0.00
Total Short-Term Assets $288.7M $232.1M
YoY Change 2.48% 2.25%
LONG-TERM ASSETS
Property, Plant & Equipment $16.44M $14.80M
YoY Change 168.89% -9.8%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $88.67M $88.10M
YoY Change -7.71% -2.06%
Total Long-Term Assets $105.1M $102.9M
YoY Change -3.87% -3.26%
TOTAL ASSETS
Total Short-Term Assets $288.7M $232.1M
Total Long-Term Assets $105.1M $102.9M
Total Assets $393.8M $335.0M
YoY Change 0.7% 0.49%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.997M $6.139M
YoY Change -25.41% -26.05%
Accrued Expenses $59.28M $61.00M
YoY Change -17.43% -2.42%
Deferred Revenue $263.1M $214.1M
YoY Change -1.02% 0.93%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $5.912M $5.912M
YoY Change 23.45% 39.86%
Total Short-Term Liabilities $336.4M $288.8M
YoY Change -4.7% 0.07%
LONG-TERM LIABILITIES
Long-Term Debt $64.23M $65.67M
YoY Change -8.25% -8.08%
Other Long-Term Liabilities $1.930M $1.718M
YoY Change -3.79% -33.28%
Total Long-Term Liabilities $66.16M $67.39M
YoY Change -8.13% -8.96%
TOTAL LIABILITIES
Total Short-Term Liabilities $336.4M $288.8M
Total Long-Term Liabilities $66.16M $67.39M
Total Liabilities $433.3M $356.2M
YoY Change -7.46% -12.85%
SHAREHOLDERS EQUITY
Retained Earnings -$202.2M -$211.6M
YoY Change -11.42% -5.13%
Common Stock $9.000K $9.000K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$39.50M -$53.05M
YoY Change
Total Liabilities & Shareholders Equity $393.8M $335.0M
YoY Change 0.7% 0.49%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income $9.351M $6.801M
YoY Change -277.37% -1779.26%
Depreciation, Depletion And Amortization $826.0K $750.0K
YoY Change 30.49% 15.56%
Cash From Operating Activities -$1.146M -$8.140M
YoY Change -38.35% -66.11%
INVESTING ACTIVITIES
Capital Expenditures $3.558M $1.550M
YoY Change 199.75% -209.0%
Acquisitions
YoY Change
Other Investing Activities $10.79M -$1.460M
YoY Change -220.38% -86.9%
Cash From Investing Activities $7.235M -$3.020M
YoY Change -171.26% -75.97%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.772M -1.770M
YoY Change 53.29% 5.29%
NET CHANGE
Cash From Operating Activities -1.146M -8.140M
Cash From Investing Activities 7.235M -3.020M
Cash From Financing Activities -1.772M -1.770M
Net Change In Cash 4.317M -12.93M
YoY Change -132.78% -66.21%
FREE CASH FLOW
Cash From Operating Activities -$1.146M -$8.140M
Capital Expenditures $3.558M $1.550M
Free Cash Flow -$4.704M -$9.690M
YoY Change 54.43% -57.11%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherAccruedLiabilitiesCurrent
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
88517000 shares
rmni Insurance Costs And Recoveries Net
InsuranceCostsAndRecoveriesNet
0 usd
rmni Insurance Costs And Recoveries Net
InsuranceCostsAndRecoveriesNet
-389000 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
1413000 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
1167000 usd
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
23614000 usd
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
0 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
27000 usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
3938000 usd
CY2021Q3 us-gaap Debt Instrument Term
DebtInstrumentTerm
P5Y
CY2021Q3 rmni Long Term Debt Maturities Repayments Of Principal Percentage In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalPercentageInNextTwelveMonths
0.05
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1014000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
4740000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
247000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
235000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
79000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
965000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-5120000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-12412000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-5109000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-11050000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-774000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-997000 usd
us-gaap Interest Paid Net
InterestPaidNet
3409000 usd
us-gaap Interest Paid Net
InterestPaidNet
2195000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
4164000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
1886000 usd
rmni Working Capital Surplus Deficit
WorkingCapitalSurplusDeficit
56700000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
6800000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
108700000 usd
CY2023Q3 us-gaap Short Term Investments
ShortTermInvestments
19900000 usd
CY2023Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
214100000 usd
CY2023Q3 rmni Cost Of Goods And Services Sold As Percentage Of Revenue
CostOfGoodsAndServicesSoldAsPercentageOfRevenue
0.37
CY2021Q3 rmni Long Term Debt Maturities Repayments Of Principal Percentage In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalPercentageInYearThree
0.075
CY2021Q3 rmni Long Term Debt Maturities Repayments Of Principal Percentage In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalPercentageInYearFour
0.075
CY2021Q3 rmni Long Term Debt Maturities Repayments Of Principal Percentage In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalPercentageInYearFive
0.10
CY2021Q4 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
36509000 usd
rmni Capitalized Commissions
CapitalizedCommissions
15620000 usd
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
300268000 usd
us-gaap Contract With Customer Asset Cumulative Catch Up Adjustment To Revenue Change In Measure Of Progress
ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress
248960000 usd
rmni Contract With Customer Liability Revenue Recognized Including Current Billings
ContractWithCustomerLiabilityRevenueRecognizedIncludingCurrentBillings
301041000 usd
CY2022Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
6878000 usd
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
9184000 usd
CY2022Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
2526000 usd
CY2022Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
333000 usd
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
2229000 usd
CY2022Q4 us-gaap Accrued Insurance Current And Noncurrent
AccruedInsuranceCurrentAndNoncurrent
6979000 usd
CY2022Q4 rmni Other Accrued Expenses Current
OtherAccruedExpensesCurrent
4547000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
32676000 usd
CY2022Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
50000000 usd
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2443000 usd
CY2023Q3 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
1000000 usd
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
88517000 shares
CY2023Q3 rmni Insurance Costs And Recoveries Net
InsuranceCostsAndRecoveriesNet
0 usd
CY2022Q3 rmni Insurance Costs And Recoveries Net
InsuranceCostsAndRecoveriesNet
92000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4158000 usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
8375000 usd
rmni Capital Expenditures Incurred But Not Yet Paid Increase Decrease
CapitalExpendituresIncurredButNotYetPaidIncreaseDecrease
669000 usd
rmni Capital Expenditures Incurred But Not Yet Paid Increase Decrease
CapitalExpendituresIncurredButNotYetPaidIncreaseDecrease
-2000 usd
CY2021Q3 us-gaap Debt Instrument Term
DebtInstrumentTerm
P5Y
CY2021Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
90000000 usd
CY2021Q3 rmni Long Term Debt Maturities Repayments Of Principal Percentage In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalPercentageInYearTwo
0.05
CY2023Q3 rmni Lessee Lease Liability Payments Due Next Rolling Twelve Months
LesseeLeaseLiabilityPaymentsDueNextRollingTwelveMonths
5600000 usd
us-gaap Use Of Estimates
UseOfEstimates
<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements and related disclosures in conformity with U.S. GAAP requires the Company to make judgments, assumptions, and estimates that affect the amounts reported in its consolidated financial statements and </span></div>accompanying notes. The Company bases its estimates and assumptions on current facts, historical experience, and various other factors that it believes are reasonable under the circumstances to determine the carrying values of assets and liabilities that are not readily apparent from other sources. The Company’s accounting estimates include, but are not necessarily limited to, valuation of accounts receivable, valuation assumptions for stock options and leases, deferred income taxes and the related valuation allowances, and the evaluation and measurement of contingencies. To the extent there are material differences between the Company’s estimates and actual results, the Company’s future consolidated results of operations may be affected.
us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
13209000 usd
CY2022Q3 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
38920000 usd
CY2022Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
248187000 usd
CY2023Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
550100000 usd
CY2022Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
532300000 usd
CY2023Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
214100000 usd
CY2023Q3 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
21000 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
1413000 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
1167000 usd
us-gaap Interest Expense
InterestExpense
4139000 usd
us-gaap Interest Expense
InterestExpense
2974000 usd
CY2023Q3 us-gaap Proceeds From Interest Received
ProceedsFromInterestReceived
200000 usd
CY2022Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
15000000 usd
CY2022Q2 us-gaap Stock Repurchase Program Period In Force1
StockRepurchaseProgramPeriodInForce1
P2Y
CY2022Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
50000000 usd
CY2022Q2 us-gaap Stock Repurchase Program Period In Force1
StockRepurchaseProgramPeriodInForce1
P4Y
CY2022Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
15000000 usd
CY2022Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
15000000 usd
us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
200000 shares
CY2022Q3 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
200000 shares
CY2022Q3 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
1000000 usd
us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
4700000 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
3500000 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
7543000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
3541000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1912000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
1960000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
213000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
288000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
177000 shares
us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
248000 shares
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
75000 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
8063000 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.55
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0375
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
4.20
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9056000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8653000 usd
CY2023Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
3400000 shares
CY2023Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
5.64
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.651
CY2022Q3 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
800000 usd
us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
2600000 usd
CY2022Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
20000000 usd
CY2023Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
20611000 usd
CY2023Q3 us-gaap Aoci Debt Securities Available For Sale Without Allowance For Credit Loss Cumulative Gain Loss After Tax
AociDebtSecuritiesAvailableForSaleWithoutAllowanceForCreditLossCumulativeGainLossAfterTax
203000 usd
CY2023Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
20814000 usd
CY2023Q3 rmni Lessee Operating Lease Terms Days Notice Required To Terminate
LesseeOperatingLeaseTermsDaysNoticeRequiredToTerminate
30 day
CY2023Q3 rmni Lessee Operating Lease Lease Not Yet Commenced Number
LesseeOperatingLeaseLeaseNotYetCommencedNumber
1 lease
CY2023Q3 rmni Lessee Operating Lease Lease Not Yet Commenced Net Present Value
LesseeOperatingLeaseLeaseNotYetCommencedNetPresentValue
500000 usd
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
1109000 usd
CY2023Q3 rmni Other Lease Cost
OtherLeaseCost
318000 usd
CY2023Q3 us-gaap Lease Cost
LeaseCost
1427000 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6339000 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4175000 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
7511000 usd
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
11686000 usd
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.100
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Rolling Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths
5078000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Two
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo
3956000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Three
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree
2806000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Four
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour
1187000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Five
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive
366000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due After Rolling Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive
94000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
13487000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1801000 usd
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
11686000 usd
CY2023Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
1300000 usd
CY2023Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001635282-23-000202-index-headers.html Edgar Link pending
0001635282-23-000202-index.html Edgar Link pending
0001635282-23-000202.txt Edgar Link pending
0001635282-23-000202-xbrl.zip Edgar Link pending
exhibit311q32023.htm Edgar Link pending
exhibit312q32023.htm Edgar Link pending
exhibit32-amendedandrestat.htm Edgar Link pending
exhibit321q32023.htm Edgar Link pending
exhibit322q32023.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rmni-20230930.htm Edgar Link pending
rmni-20230930.xsd Edgar Link pending
Show.js Edgar Link pending
rmni-20230930_cal.xml Edgar Link unprocessable
rmni-20230930_def.xml Edgar Link unprocessable
rmni-20230930_pre.xml Edgar Link unprocessable
rmni-20230930_lab.xml Edgar Link unprocessable
rmni-20230930_htm.xml Edgar Link completed